These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32345047)

  • 1. Review of the Long-Term Implantable Senseonics Continuous Glucose Monitoring System and Other Continuous Glucose Monitoring Systems.
    Joseph JI
    J Diabetes Sci Technol; 2021 Jan; 15(1):167-173. PubMed ID: 32345047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Three-Way Accuracy Comparison of the Dexcom G5, Abbott Freestyle Libre Pro, and Senseonics Eversense Continuous Glucose Monitoring Devices in a Home-Use Study of Subjects with Type 1 Diabetes.
    Jafri RZ; Balliro CA; El-Khatib F; Maheno MM; Hillard MA; O'Donovan A; Selagamsetty R; Zheng H; Damiano ER; Russell SJ
    Diabetes Technol Ther; 2020 Nov; 22(11):846-852. PubMed ID: 32453604
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System.
    Deiss D; Szadkowska A; Gordon D; Mallipedhi A; Schütz-Fuhrmann I; Aguilera E; Ringsell C; De Block C; Irace C
    Diabetes Technol Ther; 2019 May; 21(5):254-264. PubMed ID: 31021180
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact on diabetes control and patient-reported outcomes of a newer implantable continuous glucose monitoring system (Eversense® CGM System): a single-centre retro- and prospective observational study.
    Rohner DG; Burget L; Henzen C; Fischli S
    Swiss Med Wkly; 2024 Mar; 154():3366. PubMed ID: 38579290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study.
    Garg SK; Liljenquist D; Bode B; Christiansen MP; Bailey TS; Brazg RL; Denham DS; Chang AR; Akturk HK; Dehennis A; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2022 Feb; 24(2):84-92. PubMed ID: 34515521
    [No Abstract]   [Full Text] [Related]  

  • 6. A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study.
    Christiansen MP; Klaff LJ; Bailey TS; Brazg R; Carlson G; Tweden KS
    Diabetes Technol Ther; 2019 May; 21(5):231-237. PubMed ID: 30925083
    [No Abstract]   [Full Text] [Related]  

  • 7. Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.
    Kropff J; Choudhary P; Neupane S; Barnard K; Bain SC; Kapitza C; Forst T; Link M; Dehennis A; DeVries JH
    Diabetes Care; 2017 Jan; 40(1):63-68. PubMed ID: 27815290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles.
    Tweden KS; Deiss D; Rastogi R; Addaguduru S; Kaufman FR
    Diabetes Technol Ther; 2020 May; 22(5):422-427. PubMed ID: 31697182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor.
    Sanchez P; Ghosh-Dastidar S; Tweden KS; Kaufman FR
    Diabetes Technol Ther; 2019 Dec; 21(12):677-681. PubMed ID: 31385732
    [No Abstract]   [Full Text] [Related]  

  • 10. A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
    Christiansen MP; Klaff LJ; Brazg R; Chang AR; Levy CJ; Lam D; Denham DS; Atiee G; Bode BW; Walters SJ; Kelley L; Bailey TS
    Diabetes Technol Ther; 2018 Mar; 20(3):197-206. PubMed ID: 29381090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy.
    Irace C; Cutruzzolà A; Tweden K; Kaufman FR
    Expert Rev Med Devices; 2021 Oct; 18(10):909-914. PubMed ID: 34528851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes.
    Aronson R; Abitbol A; Tweden KS
    Diabetes Obes Metab; 2019 Jul; 21(7):1689-1694. PubMed ID: 30938036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference Assessment of Various Endogenous and Exogenous Substances on the Performance of the Eversense Long-Term Implantable Continuous Glucose Monitoring System.
    Lorenz C; Sandoval W; Mortellaro M
    Diabetes Technol Ther; 2018 May; 20(5):344-352. PubMed ID: 29600877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Review of the First Long-term Implantable Continuous Glucose Monitoring System Available in the United States.
    Cowart K
    J Diabetes Sci Technol; 2021 Jan; 15(1):160-166. PubMed ID: 31833388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of "Multicenter Evaluation Study Comparing a New Factory-Calibrated Real-Time Continuous Glucose Monitoring System to Existing Flash Glucose Monitoring System".
    Peyser T
    J Diabetes Sci Technol; 2023 Jan; 17(1):214-216. PubMed ID: 34651509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptability of Implantable Continuous Glucose Monitoring Sensor.
    Barnard KD; Kropff J; Choudhary P; Neupane S; Bain SC; Kapitza C; Forst T; Link M; Mdingi C; DeVries JH
    J Diabetes Sci Technol; 2018 May; 12(3):634-638. PubMed ID: 28990436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparing the accuracy of transcutaneous sensor and 90-day implantable glucose sensor.
    Boscari F; Vettoretti M; Amato AML; Vallone V; Uliana A; Iori E; Avogaro A; Facchinetti A; Bruttomesso D
    Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):650-657. PubMed ID: 33594987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Novel and Easy Method to Locate and Remove First Approved Long-Term Implantable Glucose Sensors.
    Akturk HK; Brackett S
    Diabetes Technol Ther; 2020 Jul; 22(7):538-540. PubMed ID: 32031415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.